U.S. Agencies Seize Over $7 Million in Illegal E-Cigarettes as FDA Pledges Continued Crackdown

Jan.11.2025
U.S. Agencies Seize Over $7 Million in Illegal E-Cigarettes as FDA Pledges Continued Crackdown
The Miami operation, announced on January 10, is the latest joint effort by multiple U.S. federal agencies to combat illegal e-cigarettes, resulting in the seizure of over $7 million worth of unauthorized products. The FDA emphasized that an “All Government” approach is critical in addressing the issue of illegal e-cigarettes.

Key Points:

 

1. This is another significant enforcement action following the October 2024 seizure of $76 million worth of illegal e-cigarettes.

 

2. Recently, the FDA has issued a series of announcements, including the January 3 announcement regarding updates to import alerts, allowing all unauthorized e-cigarettes to be detained without physical examination. These actions signal an acceleration of the FDA’s crackdown on illegal e-cigarettes.

 

3. In this announcement, Geek Bar was once again the only brand explicitly named, with the FDA stating that it “may appeal to youth.” This underscores the FDA’s close attention to the brand.

 

4. The details disclosed in this announcement—such as the seizure in Miami and the methods by which illegal products entered the U.S.—demonstrate the increasing precision and efficiency of enforcement under multi-agency cooperation.

 

5. The head of the FDA’s Center for Tobacco Products emphasized the importance of the “All Government” approach, in combating illegal e-cigarettes. This suggests that additional cases of illegal e-cigarette seizures may occur in the future.

 

 

 

[January 10, 2025] U.S. federal agencies announced the seizure of more than 628,000 unauthorized e-cigarette products from a warehouse in Miami, with a retail value exceeding $7 million. The confiscated items included flavored disposable e-cigarettes, kits, and batteries, with some products from brands like Geek Bar, which are known to appeal to youth.

 

The operation, led by U.S. Customs and Border Protection (CBP), uncovered shipments of illegal e-cigarette products originating from China and destined for various U.S. states. Investigations revealed that these products were intentionally misdeclared and undervalued—common tactics to evade detection and duties. Following referrals to the FDA’s Center for Tobacco Products, authorities confirmed the products lacked mandatory premarket authorization, rendering them illegal for sale or distribution in the U.S.

 

“An ‘All Government’ approach is critical to preventing unauthorized e-cigarettes from entering the United States” said Brian King, Ph.D., M.P.H., director of the FDA’s Center for Tobacco Products. “Today’s action is another step in the right direction, and we remain committed to continuing to work with our federal partners to continue to combat the entry of these illegal products head on.”

 

Confiscated products, like those seized in this operation, are typically disposed of in compliance with federal regulations. For unauthorized tobacco products, including e-cigarettes, this generally means destruction.

 

The Miami operation is part of an intensified federal crackdown on illegal e-cigarette distribution. It follows a $76 million seizure of unauthorized e-cigarettes in October 2024 and builds on efforts spearheaded by a federal task force established in June 2024 to streamline enforcement. These coordinated actions aim to hold violators accountable by leveraging criminal and civil tools across multiple agencies.

 

To date, the FDA has authorized only 34 e-cigarette products and devices for legal sale in the U.S. More information on authorized tobacco products can be found in the FDA’s Searchable Tobacco Products Database.

 

Original FDA Announcement : Over $7 Million Worth of Illegal E-Cigarettes Seized in Federal Operation

 

 

 

2Firsts Editorial Note:

 

Since the second half of 2024, U.S. agencies have continued their crackdown on illegal e-cigarettes. Through coordinated efforts across multiple federal departments, these enforcement actions have achieved increasingly significant results, reflecting the U.S. federal government’s determination and strategic optimization in combating illegal e-cigarettes.

 

2Firsts has been closely monitoring U.S. regulatory actions on e-cigarettes. At the recently concluded 2Firsts 2024 Global NGP Compliance Development Symposium, 2Firsts invited several U.S. compliance experts to provide detailed insights into U.S. compliance policies for e-cigarette companies. Additionally, in 2Firsts’ 2024 Global Top 10 NGP News, the story titled “1. U.S. E-Cigarette Regulations Intensify, Setting the Stage for a Major Market Shakeup” ranked first.

 

 

 

Recent 2Firsts reports on U.S. regulations include:

 

1.FDA Strengthens Import Alerts to Address Unauthorized E-Cigarettes Detention

 

2.FDA Warns 9 Online Firms for Illegally Selling Flavored, Disposable E-Cigarettes, Including Geek Bar and Lost Mary

 

3.FDA Outlines Recent Regulatory Actions to 2Firsts: Comprehensive Oversight and Strategies Adapting to Market Changes


4.U.S. FDA's 2024 Illicit E-Cigarette Crackdown: Full-Spectrum Enforcement and Targeted Actions Against Geekvape and Heaven Gifts

 

5.FDA, CBP seize 3 million illegal e-cigarette products worth $76 million, including GEEKBAR

 

6.U.S. Regulatory Storm to Drive Profound Changes in China's E-Cigarette Supply Chain, Says Alan Zhao, CEO of 2Firsts

 


 

2Firsts welcomes article submissions, interview opportunities, or commentary. Please contact us at info@2firsts.com or connect with 2Firsts CEO Alan Zhao on LinkedIn here.

 

U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Vaping brand PIXL has introduced the PIXL 5K reusable prefilled pod device in the UK, featuring a 2ml prefilled pod and a 4ml refill container with a combined e-liquid capacity of 6ml. The device uses 20mg/ml nicotine salt e-liquid and is advertised to deliver up to approximately 5,000 puffs. Available through UK retailers by August 2026, the PIXL 5K sits alongside the existing 12ml PIXL 8000. The UK's Vaping Products Duty took effect on October 1 at £0.22 per millilitre, producing theoretical duty amounts of £1.32 and £2.64 for the two products' respective full refill sets.
product
Oct.10
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21